Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

BPC-157 Dosage Guide, Side Effects & Legal Status

BPC-157 Dosage Guide, Side Effects & Legal Status BPC-157 is studied for accelerating tendon, gut, and muscle healing through angiogenesis and growth factor signaling. See dosing and research. Chemical Makeup 15 Amino Acids BPC-157 Gly Position 1 Glu Position

BPC-157 Dosage Guide, Side Effects & Legal Status

BPC-157 is studied for accelerating tendon, gut, and muscle healing through angiogenesis and growth factor signaling. See dosing and research.

Chemical Makeup

15

Amino Acids

BPC-157

Gly

Position 1

Glu

Position 2

Pro

Position 3

Position 4

Position 5

Position 6

Lys

Position 7

Position 8

Ala

Position 9

Asp

Position 10

Position 11

Position 12

Position 13

Leu

Position 14

Val

Position 15

As seen on

BPC-157 Dosage Guide for Recovery & RepairBPC-157 Dosage Calculator

BPC-157 is a peptide known for helping the body heal tissue faster.

Vial size

10 mg

Bacteriostatic water

3 mL

Dosing

250–500 mcg

Frequency

Daily

Cycle

As needed

Benefit

Recovery & Repair

What is BPC-157?

BPC-157 is a peptide based on a natural, protective substance found in the stomach, and it's one of the most widely used research peptides for healing. It works by boosting blood vessel growth and supporting the body's natural repair signals, which is why it's popular for helping injuries like pulled muscles, sprained ligaments, and tendon problems heal faster. It's also studied for gut health, and is commonly used by athletes and in injury-recovery research, though it isn't an approved medication.

Healing

Research targets include tissue repair, wound healing, and recovery from injury.

Longevity

Research targets include cellular aging, senescence, and long-term healthspan.

bpc

Is BPC-157 FDA approved?

BPC-157 is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.

Research Use Only

BPC-157 has not been evaluated by the FDA for safety or efficacy in humans.

No Clinical Oversight

Not manufactured under FDA-regulated quality or clinical standards.

Unregulated Sourcing

Purity, dosing, and sourcing are not verified through FDA testing or oversight.

Our top-rated vendor

View all vendors

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing — no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health

#1 Rated Research Peptide Supplier

How Does BPC-157 Work?

It switches on signals that trigger new blood vessel growth and nitric oxide production, both of which are essential for healing. It also activates pathways that encourage the cells responsible for repairing tissue to multiply and migrate to the site of injury, and it makes tendon tissue more responsive to the body's own growth hormone.

Triggers blood vessel growth

Switches on signals for new blood vessels and nitric oxide, both key to healing.

Recruits repair cells

Activates pathways that help repair cells multiply and migrate to the injury.

Boosts GH response

Makes tendon tissue more responsive to the body's own growth hormone.

BPC-157 Targeted areas

How to reconstitute BPC-157

The materials you'll need and step-by-step instructions for safely mixing BPC-157 with bacteriostatic water.

Materials needed

Your BPC-157 vial (lyophilized)

Alcohol swabs

Bacteriostatic sterile water

3 mL syringes (Luer Lock tip)

25G or 27G needles (Luer Lock). Other gauges may also be acceptable.

Sharps container (optional)

Remove the caps

Sanitize the rubber stoppers

Attach the needle

Draw the bac water

Pull back on the plunger to draw your desired volume of bacteriostatic water. If you overfill, just push the excess back in until you reach the right marker on the syringe.

Insert the needle into the BPC-157 vial

With the bac water in your syringe, insert the needle into the BPC-157 vial at a slight angle to avoid pressure buildup.

Release the water gently

Let the water run gently down the side of the vial. Don't inject it forcefully.

Swirl to dissolve

Avoid shaking. Gently swirl, flip, and roll the vial to dissolve the powder.

Check for full dissolution

Cap, dispose, and store

How to Store BPC-157

The dry powder keeps in the freezer for up to 2–3 years. Once mixed with bacteriostatic water, refrigerate it and use within about a month, and try not to freeze and thaw it repeatedly.

Lyophilized Storage

Store at -20°C, stable up to 24–36 months.

Reconstituted Storage

With bacteriostatic water, refrigerate at 2–8°C for up to 4 weeks.

Handling Notes

Protect from repeated freeze-thaw cycles.

What Are the Benefits of BPC-157?

What research says it may help with, and how it works in the body.

wound healing

Speeds up healing and shortens recovery time after crush injuries or surgery, working directly at the site of the damaged tissue.

Encourages new blood vessels to form and improves blood flow to tissue, when delivered directly to the area.

Helps tendons heal into bone faster and makes the repaired tissue stronger and more functional. It works best when injected directly at the injury site.

neurological

In animal studies, it protected brain cells from toxic substances and from damage caused by reduced blood flow to the brain, as happens in a stroke.

In studies on spinal cord injuries, it helped animals recover function better and reduced the amount of tissue damage.

Helps nerves outside the brain and spinal cord regrow and regain function after being injured.

gastrointestinal

Speeds up healing of the intestines and lowers markers of inflammation in studies modeling inflammatory bowel disease.

Strengthens the protective lining of the gut and speeds up the regrowth of the surface cells that make up that lining.

Helps protect the stomach and the first part of the small intestine from ulcers by shielding the cells that line these organs.

What Are the Side Effects of BPC-157?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

Active cancer (due to angiogenic effects)

Pregnancy or breastfeeding

Blood thinners (consult doctor due to angiogenesis)

WADA prohibited for competitive athletes

Stop Right Away If You Notice

Persistent injection site reactions or infection signs

Unusual swelling or rash around injection area

Severe headaches or dizziness

Allergic reactions

Persistent or worsening digestive issues

Milder Signs to Watch For

Peptides Commonly Stacked With BPC-157

Peptides that are commonly stacked with BPC-157, and the blends that combine them.

glow

Skin

Glow Blend (GHK-Cu, BPC-157, TB-500)

Preclinical

klow

Klow Blend (GHK-Cu, KPV, BPC-157, TB-500)

core

Coremend Blend (BPC-157, KPV, TB-500)

Limited Research

wol

Wolverine Blend (BPC-157, TB-500)

How Long Should a BPC-157 Cycle Last?

This breaks down how long a typical BPC-157 cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Related peptides

aba

Abaloparatide

Fda Approved

Growth

hgh

HGH

igf

IGF-1 LR3

kpv

Immunity

KPV

Cheat Sheets Featuring BPC-157

See how BPC-157 fits into a broader research stack with these free downloadable cheat sheets. Each one includes reference dose ranges, dosing frequency, and half-life for every peptide it covers. For research purposes only.

18 peptides

42 peptides

78 peptides

Browse user-created protocols

Real protocols from the community that include BPC-157

BPC157 ,GHKCU,RT20, MOTSC

N

ghk

Weight

cjc

Recovery Protocol

Ryan

tb5

Immune and Autoimmune Support

Bryn

thymo

Recovery and Injury Protocol

BPC-157 Research References

It is a preclinical compound

BPC-157 is a preclinical compound

Accelerated quadriceps healing with improved histology, reduced inflammation, and restored function in rat models.

2006

Significant functional recovery, reduced tissue damage, and improved neurological outcomes in rat models.

2019

Cytoprotective effects against gastric ulcers through multiple protective mechanisms.

2020

Pro-angiogenic effects via VEGFR2 activation, explaining wound healing mechanisms.

2017

No serious adverse effects at therapeutic doses up to 1000 μg/kg for 90 days; established safety profile.

Superior tendon healing with improved biomechanical properties and enhanced tendon-to-bone integration in rat models.

2003

Frequently Asked Questions About BPC-157

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.

What is BPC-157?

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide (15 amino acids) derived from a protective protein found in human gastric juice. In animal and in-vitro studies it has been associated with promoting angiogenesis (new blood vessel formation), enhancing collagen production, and modulating inflammation, which together are thought to support tissue repair in the gut, tendons, ligaments, and muscle. It is sold almost exclusively as a research chemical and is not approved by the FDA or other regulators for human use.

What dosage do people typically use?

In research and anecdotal-use protocols, doses commonly cited range from about 200 to 1,000 mcg (0.2–1 mg) per day, often split into one or two administrations. Many protocols start around 250–300 mcg/day for general maintenance and increase toward 500 mcg/day or higher for more significant tissue injury. These figures come from clinic guidance and user reports rather than controlled human clinical trials, so there is no officially established or medically validated human dose.

How long is a typical cycle, and should you take breaks?

A commonly followed pattern is 4–8 weeks of continuous use followed by a break of several weeks before restarting, though these cycling schedules are based on general peptide-use conventions rather than clinical dosing studies specific to BPC-157. Because long-term human safety data doesn't exist, many users and practitioners favor time-limited cycles tied to a specific injury or goal rather than indefinite continuous use.

Injection, oral capsule, or both — which is 'better'?

Most of the preclinical research demonstrating BPC-157's tissue-repair effects used injectable (subcutaneous or intramuscular) administration, which bypasses digestion and is generally considered to have higher systemic bioavailability. Oral capsules are more convenient and are commonly used for gut-related concerns (BPC-157 was originally derived from gastric juice and is notably stable in the digestive tract), but a smaller fraction is thought to reach systemic circulation, so oral doses are sometimes set higher to compensate. There is no direct human bioequivalence study comparing the two routes.

What side effects have been reported?

Reported side effects are generally described as mild: transient injection-site redness, a small bump, or stinging that typically resolves within 24 hours for subcutaneous use, and occasional nausea, fatigue, headache, or dizziness. Animal toxicity studies found no deaths even at doses far exceeding typical use levels, but formal human clinical safety data is very limited, so the long-term safety profile — especially with repeated cycles — remains largely unestablished.

How should BPC-157 be stored and reconstituted?

Lyophilized (freeze-dried) BPC-157 powder is generally kept refrigerated (or frozen at -20°C or colder for longer-term storage) and protected from light and moisture until use. It's typically reconstituted with bacteriostatic water, which contains a small amount of benzyl alcohol to inhibit microbial growth during repeated use. Once mixed, the solution is usually stored refrigerated at about 2–8°C and used within roughly 2–6 weeks, as stability decreases over time at refrigerator temperature and more quickly at room temperature.

Is BPC-157 legal to buy and use?

BPC-157 is not FDA-approved for any human medical use and, in the U.S., has increasingly been restricted from compounding pharmacies; it is typically sold labeled 'for research purposes only, not for human consumption.' Legal status varies by country and can change, and purchasing or using it for personal/human use exists in a legal and regulatory gray area in many jurisdictions. Buyers should check current local regulations rather than assume research-labeled products are legal to consume.

Is BPC-157 commonly stacked with other peptides, like TB-500?

Yes — BPC-157 is frequently discussed alongside TB-500 (thymosin beta-4) in recovery-focused peptide protocols, with users pairing them on the premise that they act through different but complementary healing pathways. As with BPC-157 alone, evidence for combined use comes mainly from anecdotal reports and animal research rather than controlled human trials, so claims about added benefit from stacking are not clinically established.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Dosage Protocols

Since BPC-157 is not FDA-approved for human use, there are no officially established dosing guidelines. The following information reflects dosages commonly reported in research literature and anecdotal use. Standard Dosing Range: Low dose: 200 to 250 mcg once daily Moderate dose: 250 to 500 mcg once or twice daily Higher dose: 500 to 800 mcg once or twice daily Weight-Based Dosing: Based on animal study extrapolations, an estimated human equivalent dose is approximately 1.6 mcg/kg body weight, translating to roughly 110 mcg for a 150-pound person and 145 mcg for a 200-pound person when using oral administration. Cycling Guidelines: Typical cycle length: 4 to 8 weeks Some users employ 4 weeks on, 2 to 4 weeks off protocols For acute injuries, shorter cycles of 2 to 4 weeks may be utilized Chronic conditions may warrant longer cycles under appropriate guidance
02

Question drills

Open a question for its connected answer.

01What If I Don't See Symptom Relief Within the First Week?+

Reassess dosing first. Subtherapeutic doses delay the VEGF upregulation response that drives initial stabilisation. Research models typically use 200–500 mcg/kg; if you're significantly below that range (adjusted for human equivalent dosing), you may not reach the threshold for angiogenic signalling. Second consideration: lesion severity. Transmural ulcers with significant inflammatory burden take longer to stabilise than superficial erosions. If you're 10 days in with zero symptom change, consider whether concurrent factors (ongoing NSAID use, H. pylori infection, high alcohol consumption) are actively counteracting the peptide's protective effects.

SOURCE / realpeptides.co ↗
02What If I'm Considering BPC-157 Based on Anecdotal Reports — What Should I Know?+

Anecdotal reports of symptom improvement with BPC-157 in IBS are common in patient forums and compounding pharmacy marketing, but they lack the controls necessary to separate real pharmacological effect from placebo response. IBS has a documented placebo response rate of 30–40% in clinical trials. Meaning nearly half of patients report improvement on inert treatment. Unblinded self-administration of a novel peptide with theoretical mechanistic plausibility is exactly the scenario where placebo effects are maximised. If you're using BPC-157 based on anecdotal evidence, track objective markers. Stool frequency, Bristol stool scale scores, validated IBS-SSS questionnaires. Not just subjective impressions.

SOURCE / realpeptides.co ↗
03What If I Only Have Access to Standard Insulin Syringes for Both Reconstitution and Injection?+

Use them for injection only—never for reconstitution. Draw bacteriostatic water with the insulin syringe, but instead of puncturing the peptide vial, transfer the water to a separate sterile container, then draw it back through a filtered needle (0.22 micron) if available before adding to the vial. This two-step process prevents the insulin needle from coring the stopper during the high-pressure injection phase of reconstitution. It adds 30-45 seconds to your protocol but eliminates 60-80% of particulate contamination compared to direct insulin syringe reconstitution. If you must use insulin syringes for direct reconstitution, puncture the stopper at a perpendicular angle and avoid lateral needle movement inside the vial—side-to-side motion is what shaves rubber particles loose.

SOURCE / realpeptides.co ↗
04What If the Study Requires Oral Administration?+

BPC-157 remains stable in gastric acid and shows systemic bioavailability after oral dosing in rat models, unlike TB-500 or most peptide growth factors which require injection. A 2019 study in the European Journal of Pharmacology demonstrated equivalent healing outcomes between oral and subcutaneous BPC-157 in ligament injury models. Oral dosing at 10mcg/kg produced 89% of the tensile strength improvement seen with injectable dosing. For non-invasive study designs or chronic administration protocols, BPC-157's oral stability is a documented advantage not shared by comparator peptides.

SOURCE / realpeptides.co ↗
05What If My Reconstituted BPC-157 Was Left Out Overnight?+

Discard it and reconstitute a fresh vial. There's no reliable way to verify potency after a temperature excursion. Peptide bonds are temperature-sensitive; even 6–8 hours at room temperature (20–25°C) causes partial denaturation that neither visual inspection nor home testing can detect. The 2019 stability study in Pharmaceutical Research showed BPC-157 solutions stored at 25°C for 24 hours retained only 62% of initial activity by HPLC assay. Using degraded peptide means injecting an unknown fraction of the intended dose.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Community Research

Join others researching BPC-157 — share findings, ask questions, and learn from real experiences Synthetic peptide derived from gastric juice protein, renowned for tissue repair, inflammation reduction, and GI protection capabilities. BPC-157 promotes blood vessel formation, enhances collagen synthesis, modulates growth factor expression, and protects against tissue damage through localized or systemic delivery. Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways.

RESEARCH

Neurological and CNS research

A growing body of preclinical research has examined BPC-157 dosage protocols in neurological injury models, including traumatic brain injury, spinal cord damage, and peripheral nerve crush models. BPC-157 dosage in these studies typically mirrors the standard musculoskeletal range — 10 mcg/kg administered IP or SC once daily — with treatment durations of 14 to 28 days post-injury. Observed outcomes in rodent models include improved motor recovery scores, reduced lesion volume, and enhanced axonal regrowth markers, though these findings remain strictly preclinical. BPC-157 has also been investigated in models of stress-induced organ damage, including restraint stress, corticosteroid-induced toxicity, and NSAID-induced gastric injury. In these models, the protective and reversive effects of BPC-157 dosage were observed within the same 10 mcg/kg range used in structural injury models, further supporting the broad-spectrum tissue-protective mechanism of this peptide.

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

BPC-157 Dosage Guide: A Comparison of Administration Routes

When developing your BPC-157 dosage guide, the choice of administration route isn't trivial; it's a foundational decision that impacts everything else. Researchers often weigh the…

Comparison

Comparison Table: Dosage Calculation Methodologies

Choosing the right approach to calculate BPC-157 dosage involves weighing several factors. Here's a quick comparison of common methods and their implications: Manual Calculation U…